Skip to main content
Sopharma Properties REIT logo

Sopharma Properties REIT — Investor Relations & Filings

Ticker · SFI ISIN · BG1100031068 LEI · 8945008OK90PXHE1RL82 BSOBGN Real estate activities
Open in API
Filings indexed 69 across all filing types
Latest filing 2026-01-29 Audit Report / Informat…
Country BG Bulgaria
Listing BSOBGN SFI

About Sopharma Properties REIT

https://sopharma-imoti.com/english-home/

Sopharma Properties REIT is a special purpose investment company that focuses on the securitization of real estate. The company's primary activity involves investing in the real estate sector by acquiring, developing, and constructing properties. These assets are primarily managed for rental and leasing purposes. The company also engages in the selling of properties and provides real estate management services on a fee basis. Its investment strategy includes purchasing titles and other rights over land and various real estate assets.

Recent filings

Filing Released Lang Actions
676241-SFI Q4_2025-dopinfo chl 31 ZDCICDS.pdf
Audit Report / Information Classification · 95% confidence The document is a regulatory disclosure titled 'Additional Information' (Допълнителна информация) pursuant to specific Bulgarian legal articles (ZDSITsDS and Ordinance No. 2). It provides detailed operational and financial compliance data for 'Sopharma Imoti' REIT as of December 31, 2025. It covers asset allocation, investment compliance, and property management metrics. Since it is a formal regulatory disclosure regarding the company's operations and compliance status rather than a full annual report, a conference call, or a simple announcement, it falls under the 'Regulatory Filings' category. FY 2025
2026-01-29 Bulgarian
676236-SFI_Q42025.xlsx.p7m.p7m
Regulatory Filings
2026-01-29 Bulgarian
676232-SFI_FS 2025 Q4.pdf
Annual Report Classification · 100% confidence The document is a comprehensive financial report for Sopharma Imoti ADSIC, containing a Statement of Comprehensive Income, Statement of Financial Position, Statement of Cash Flows, and Statement of Changes in Equity for the period ending December 31, 2025. It includes detailed financial tables and is signed by the Executive Director and Chief Accountant. As it covers a full fiscal year period and provides substantive financial statements, it is classified as an Annual Report (10-K). FY 2025
2026-01-29 Bulgarian
676254-SFI Q4_2025_info_pril. №4 Nar 2.pdf
Notice of Dividend Amount Classification · 95% confidence The document is a formal regulatory filing submitted by 'Sopharma Imoti' ADSIC to the Financial Supervision Commission (FSC) of Bulgaria. It follows the structure of 'Appendix No. 4' as required by local regulations (Ordinance No. 2), which mandates periodic disclosure of significant corporate events, shareholder changes, dividend distributions, and financial updates for the fiscal year 2025. Since it provides a comprehensive summary of management's activities, governance, and financial disclosures for the period, but is not the full audited annual report itself, it falls under the category of Management Reports (MDA), which covers management's detailed explanation of business trends, outlook, and operational disclosures.
2026-01-29 Bulgarian
676250-SFI Q4_2025_doklad_za_Deinostta.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Interim Activity Report' (Междинен доклад за дейността) for the period ending 31.12.2025. It contains detailed financial statements, analysis of revenue, expenses, capital resources, and management commentary. It is a comprehensive financial report for a period shorter than a full fiscal year (interim), fitting the definition of an Interim/Quarterly Report (IR). FY 2025
2026-01-29 Bulgarian
676239-SFI_Q4_2025-prepratka za v. info_chl 7 Regl_596.pdf
Regulatory Filings Classification · 95% confidence The document is a chronological summary of regulatory disclosures and internal information announcements made by 'Sopharma Imoti' ADSIC throughout the 2025 fiscal year. It lists various events such as the publication of financial reports, dividend announcements, shareholder meeting protocols, and director dealings. Because this document serves as a consolidated list of regulatory filings and announcements rather than a single specific report (like a 10-K or an Earnings Release), it falls under the category of general regulatory filings.
2026-01-29 Bulgarian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.